Nonsupine Positioning after Macular Hole Surgery: A Prospective Multicenter Study

Ophthalmol Retina. 2019 May;3(5):388-392. doi: 10.1016/j.oret.2018.12.006. Epub 2018 Dec 31.

Abstract

Purpose: To evaluate the postoperative closure rate of full-thickness macular holes (MHs) after nonsupine positioning, which means that the patients avoid upward gaze and a supine sleeping position, and to investigate the correlation between postoperative positioning compliance and closure rate.

Design: Prospective, multicenter study (ClinicalTrials.gov identifier, NCT02295943).

Participants: Patients undergoing primary surgery for primary MH.

Methods: Patients underwent pars plana vitrectomy with internal limiting membrane peeling and sulfur hexafluoride gas tamponade followed by 3 to 5 days of nonsupine positioning. A positioning measuring device that recorded the time spent in the supine position was attached to patients' forehead after surgery for 24 hours.

Main outcome measures: Anatomic closure rate of MH at 2 weeks or more after surgery and the time spent in supine position during the first 24 hours after surgery.

Results: A total of 205 participants were included, of whom 2 were lost to follow-up. Two hundred two of 203 MHs closed after a single operation, giving a closure rate of 99.5% (95% confidence interval, 97.3%-99.9%). The median time of supine positioning during the first 24 hours was 28 seconds (range, 0:00:00-01:52:28). Because of the very high closure rate, a correlation between positioning compliance and closure rate could not be established.

Conclusions: Pars plana vitrectomy with internal limiting membrane peeling followed by a short-term nonsupine positioning accomplished a very high MH closure rate. Thus, face-down positioning was not necessary to achieve excellent closure rates in this study.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Basement Membrane / surgery
  • Endotamponade
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patient Positioning / methods*
  • Postoperative Period
  • Prone Position*
  • Prospective Studies
  • Retinal Perforations / surgery*
  • Visual Acuity
  • Vitrectomy*

Associated data

  • ClinicalTrials.gov/NCT02295943